# UV-Cap

> UV-Cap is a VC fund in Ravensburg backing Personal Health, Big Data and Software. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Ravensburg, Germany
- Total investments: 2
- Last investment: Jan 2021
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://www.uvcap.de/

UV-Cap is a German family office that invests in mid-size cooperations that have great potential in their markets in the "b-to-b" business. It is based in Ravensburg, Germany.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Personal Health | 2 | 100% |
| Big Data | 1 | 50% |
| Software | 1 | 50% |
| Wellness | 1 | 50% |
| Health Care | 1 | 50% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 1 | 50% |
| Germany | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PatchAi | PatchAi Srl is an innovative start-up aiming to transform late phase and Real-world studies by virtue of focus on patient centricity and forefront digital technologies, such as Artificial Intelligence (AI), Machine Learning (ML) and Natural Language Generation (NLG). Our aim is to develop solutions dedicated to safer, faster and affordable medicalproduct development for the betterment of patients’ lives. Our first product is PatchAi, the first cognitive platform that champions patient engagement to revolutionize data collection through the adoption of Co-PRO™ (Conversational Patient-Reported Outcomes) and the integration of data-points from various systems to generate ground-breaking insights in real-time. | $2.1M | Seed | Jan 14, 2021 |  |
| Perfood | Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects. | $6M | Series A | Nov 30, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Healthware Ventures](https://shizune.co/investors/profile/healthware-ventures) — VC Fund, 1 deal together
- [SFEM Italia](https://shizune.co/investors/profile/sfem-italia) — VC Fund, 1 deal together
- [Verve Ventures](https://shizune.co/investors/profile/verve-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in Italy](https://shizune.co/investors/medical-device-vc-funds-italy)
- [Artificial intelligence VC Funds in Italy](https://shizune.co/investors/artificial-intelligence-vc-funds-italy)
- [Big Data Investors in Italy](https://shizune.co/investors/big-data-investors-italy)
- [Big Data VC Funds in Italy](https://shizune.co/investors/big-data-vc-funds-italy)

## FAQ

### What does UV-Cap invest in?

UV-Cap invests primarily in Personal Health, Big Data and Software startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did UV-Cap last invest?

The most recent investment recorded for UV-Cap closed in Jan 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co